Quantcast
Home / Courts / 4th Circuit / Tort/Negligence – Failure-to-warn claims about medication preempted (access required)

Tort/Negligence – Failure-to-warn claims about medication preempted (access required)

Allegations that a pharmaceutical company did not sufficiently warn about certain risks of taking an anti-stroke medication were preempted by federal law because it did not have unilateral authority to change the warning label. Background Boehringer Ingelheim Pharmaceuticals Inc. developed Pradaxa to help reduce the risk of stroke. The FDA approved the drug and its label. After ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*